Article
FDA approves Valneva's Chikungunya vaccine for adults
Rating:
0.0
Views:
41
Likes:
1
Library:
1
French drugmaker Valneva said on Friday the U.S. Food and Drug Administration (FDA) has approved its Chikungunya single-dose vaccine in individuals aged 18 and above.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value